A genome-wide association study identifies 5 loci associated with frozen shoulder and implicates diabetes as a causal risk factor

Harry D Green, Alistair Jones, Jonathan P Evans, Andrew R Wood, Robin N Beaumont, Jessica Tyrrell, Timothy M Frayling, Christopher Smith, Michael N Weedon, Harry D Green, Alistair Jones, Jonathan P Evans, Andrew R Wood, Robin N Beaumont, Jessica Tyrrell, Timothy M Frayling, Christopher Smith, Michael N Weedon

Abstract

Frozen shoulder is a painful condition that often requires surgery and affects up to 5% of individuals aged 40-60 years. Little is known about the causes of the condition, but diabetes is a strong risk factor. To begin to understand the biological mechanisms involved, we aimed to identify genetic variants associated with frozen shoulder and to use Mendelian randomization to test the causal role of diabetes. We performed a genome-wide association study (GWAS) of frozen shoulder in the UK Biobank using data from 10,104 cases identified from inpatient, surgical and primary care codes. We used data from FinnGen for replication and meta-analysis. We used one-sample and two-sample Mendelian randomization approaches to test for a causal association of diabetes with frozen shoulder. We identified five genome-wide significant loci. The most significant locus (lead SNP rs28971325; OR = 1.20, [95% CI: 1.16-1.24], p = 5x10-29) contained WNT7B. This variant was also associated with Dupuytren's disease (OR = 2.31 [2.24, 2.39], p<1x10-300) as were a further two of the frozen shoulder associated variants. The Mendelian randomization results provided evidence that type 1 diabetes is a causal risk factor for frozen shoulder (OR = 1.03 [1.02-1.05], p = 3x10-6). There was no evidence that obesity was causally associated with frozen shoulder, suggesting that diabetes influences risk of the condition through glycemic rather than mechanical effects. We have identified genetic loci associated with frozen shoulder. There is a large overlap with Dupuytren's disease associated loci. Diabetes is a likely causal risk factor. Our results provide evidence of biological mechanisms involved in this common painful condition.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Manhattan plot of discovery GWAS…
Fig 1. Manhattan plot of discovery GWAS for frozen shoulder in UK Biobank.
The plot shows–log10(p) values for each single nucleotide polymorphism [SNP] in the HRC Imputation Panel and their association with frozen shoulder defined by ICD10, OPCS codes and GP records with p −8. Positions are based on the hg19 reference human genome.
Fig 2. Two Sample Mendelian Randomization Results,…
Fig 2. Two Sample Mendelian Randomization Results, showing for each SNP in the Type 1 Diabetes GRS in [20], the log-odds ratio for type 1 diabetes on the x axis and the log-odds ratio for frozen shoulder (defined by ICD-10, OPCS and GP records) on the y axis.
Fig 3. Two Sample Mendelian Randomization Results,…
Fig 3. Two Sample Mendelian Randomization Results, showing for each SNP in the Type 1 Diabetes GRS in [20], the log-odds ratio for type 2 diabetes on the x axis and the log-odds ratio for frozen shoulder (defined by ICD-10, OPCS and GP records) on the y axis.

References

    1. Morén-Hybbinette I, Moritz U, Scherstén B. The clinical picture of the painful diabetic shoulder—natural history, social consequences and analysis of concomitant hand syndrome. Acta Med Scand. 1987;221:73–82. doi: 10.1111/j.0954-6820.1987.tb01247.x
    1. Zreik NH, Malik RA, Charalambous CP. Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence. Muscles Ligaments Tendons J. 2016;6:26–34. doi: 10.11138/mltj/2016.6.1.026
    1. Hand C, Clipsham K, Rees JL, Carr AJ. Long-term outcome of frozen shoulder. J shoulder Elb Surg. 2008;17:231–236. doi: 10.1016/j.jse.2007.05.009
    1. Uppal HS, Evans JP, Smith C. Frozen shoulder: A systematic review of therapeutic options. World J Orthop. 2015;6:263–268. doi: 10.5312/wjo.v6.i2.263
    1. Tachmazidou I, Hatzikotoulas K, Southam L, Esparza-Gordillo J, Haberland V, Zheng J, et al.. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat Genet. 2019;51:230–236. doi: 10.1038/s41588-018-0327-1
    1. Huang Y-P, Fann C-Y, Chiu Y-H, Yen M-F, Chen L-S, Chen H-H, et al.. Association of diabetes mellitus with the risk of developing adhesive capsulitis of the shoulder: a longitudinal population-based followup study. Arthritis Care Res (Hoboken). 2013;65:1197–1202. doi: 10.1002/acr.21938
    1. Kingston K, Curry EJ, Galvin JW, Li X. Shoulder adhesive capsulitis: epidemiology and predictors of surgery. J shoulder Elb Surg. 2018;27:1437–1443. doi: 10.1016/j.jse.2018.04.004
    1. Smith SP, Devaraj VS, Bunker TD. The association between frozen shoulder and Dupuytren’s disease. J shoulder Elb Surg. 2001;10:149–151. doi: 10.1067/mse.2001.112883
    1. Davies NM, Holmes M V, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601
    1. Corbin LJ, Richmond RC, Wade KH, Burgess S, Bowden J, Smith GD, et al.. BMI as a modifiable risk factor for type 2 diabetes: Refining and understanding causal estimates using mendelian randomization. Diabetes. 2016;65:3002–3007. doi: 10.2337/db16-0418
    1. Holmes M-V, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, et al.. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36:539–550. doi: 10.1093/eurheartj/eht571
    1. FinnGen. FinnGen Documentation of R3 release. 2020 [cited 26 Oct 2020]. Available from: .
    1. Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al.. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–209. doi: 10.1038/s41586-018-0579-z
    1. Alser O, Craig RS, Lane JCE, Uribe AP, Robinson DE, Rees JL, et al.. Serious complications and risk of re—operation after Dupuytren’s disease surgery: a population—based cohort study of 121, 488 patients in England. Sci Rep. 2020;1–10. doi: 10.1038/s41598-019-56847-4
    1. Sharp SA, Rich SS, Wood AR, Jones SE, Beaumont RN, Harrison JW, et al.. Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. 2019;42:200–207. doi: 10.2337/dc18-1785
    1. Tyrrell JS, Yaghootkar H, Freathy RM, Hattersley AT, Frayling TM. Parental diabetes and birthweight in 236 030 individuals in the UK Biobank Study. 2013;1714–1723. doi: 10.1093/ije/dyt220
    1. Loh P-R, Kichaev G, Gazal S, Schoech AP, Price AL. Mixed-model association for biobank-scale datasets. Nature genetics. 2018. pp. 906–908. doi: 10.1038/s41588-018-0144-6
    1. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al.. LocusZoom: regional visualization of genome-wide association scan results. 2010;26:2336–2337. doi: 10.1093/bioinformatics/btq419
    1. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318–1330. doi: 10.1126/science.aaz1776
    1. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010/07/08. 2010;26:2190–2191. doi: 10.1093/bioinformatics/btq340
    1. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010/10/05. 2010;26:2867–2873. doi: 10.1093/bioinformatics/btq559
    1. Bowden J, Smith GD, Burgess S. Mendelian Randomization Methodology Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. 2015;512–525. doi: 10.1093/ije/dyv080
    1. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016/04/07. 2016;40:304–314. doi: 10.1002/gepi.21965
    1. Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, et al.. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care. 2016;39:337–344. doi: 10.2337/dc15-1111
    1. Mahajan A, Go MJ, Zhang W, Below JE, Gaulton KJ, Ferreira T, et al.. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46:234–244. doi: 10.1038/ng.2897
    1. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè A-V, Steinthorsdottir V, et al.. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990. doi: 10.1038/ng.2383
    1. Howe LJ, Tudball M, Smith GD, Davies NM. Interpreting mendelian randomization estimates of the effects of categorical exposures such as disease status and educational attainment. medRxiv. 2020. doi: 10.1101/2020.12.14.20248168
    1. Kamal N, McGee SL, Eng K, Brown G, Beattie S, Collier F, et al.. Transcriptomic analysis of adhesive capsulitis of the shoulder. J Orthop Res Off Publ Orthop Res Soc. 2020;38:2280–2289. doi: 10.1002/jor.24686
    1. Ng M, Thakkar D, Southam L, Werker P, Ophoff R, Becker K, et al.. A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis. Am J Hum Genet. 2017;101:417–427. doi: 10.1016/j.ajhg.2017.08.006
    1. ten Dam E-JPM, van Beuge MM, Bank RA, Werker PMN. Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease. J Cell Commun Signal. 2016;10:33–40. doi: 10.1007/s12079-015-0312-8
    1. Green HD. Manhattan Plots for visualisation of GWAS results. A function for plotting a Manhattan Plot in MATLAB directly from a text file of GWAS statistics from PLINK, BOLT-LMM or SAIGE. GB. 2019. Available from: .

Source: PubMed

3
Abonner